SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-24-000550
Filing Date
2024-03-18
Accepted
2024-03-18 16:05:45
Documents
15
Period of Report
2024-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084130_8k.htm   iXBRL 8-K 35285
2 EXHIBIT 99.1 g084130_ex99-1.htm EX-99.1 9136
3 GRAPHIC image_001.jpg GRAPHIC 3290
  Complete submission text file 0001753926-24-000550.txt   228766

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE chro-20240313.xsd EX-101.SCH 3021
5 XBRL LABEL FILE chro-20240313_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE chro-20240313_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT g084130_8k_htm.xml XML 3749
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 24759006
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)